Stock Events

Rockwell Medical 

€3.32
47
+€0.2+6.27% Thursday 14:34

Statistiche

In rialzo oggi
3.32
In ribasso oggi
3.2
In rialzo da 52 settimane
-
In ribasso da 52 settimane
-
Volume
599
Volume medio
-
Cap. di mercato
97.63M
Rapporto P/E
-
Rendimento da dividendi
-
Dividendo
-

Prossimamente

Guadagni

11NovAtteso
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Avanti
-0.18
-0.11
-0.05
0.02
EPS attesi
0.01
EPS effettivi
N/D

Le persone seguono anche

Questo elenco si basa sulle watchlist delle persone su Stock Events che seguono RWMA.F. Non rappresenta una raccomandazione d'investimento.

Concorrenti

Questo elenco è un'analisi basata su recenti eventi di mercato. Non è una raccomandazione di investimento.

Info

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Show more...
CEO
Dr. Mark Strobeck Ph.D.
Dipendenti
237
Paese
US
ISIN
US7743743004
WKN
000A3DL8F

Quotazioni